Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
PASG | Passage BIO, Inc. | Chief Operating Officer | $339K | Dec 8, 2021 | ||
TERN | Terns Pharmaceuticals, Inc. | Director | $150K | -$434K | -74.3% | Sep 9, 2024 |
CMMB | Chemomab Therapeutics Ltd. | Director | Jun 16, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|